Skip to main content

Advertisement

SpringerLink
Log in

Single-fraction radiation therapy provides highly effective palliation for cutaneous T cell lymphoma

  • Original Research
  • Published:
Journal of Radiation Oncology

Abstract

Purpose/objective(s)

We report our experience with single-fraction radiation therapy in treating limited extent CTCL lesions for palliation.

Materials/methods

We reviewed 65 lesions in 18 patients with stage IA–IIB CTCL treated with a single fraction at our institution from December 2014 to April 2016. Fifteen patients had mycosis fungoides; all others (three) had primary cutaneous anaplastic large cell lymphoma. Clinical response to treatment was defined as complete response (CR, 90–100% reduction), partial response (PR, >50% but <90%), and no response (NR).

Results

All lesions were treated to a dose of 8 Gy, with a mean follow-up for all patients of 9 months (range 1–21 months). There was a CR in 61 (93.8%) lesions. Three lesions (3.8%) had an initial PR and one (1.5%) had NR; all were re-treated to a dose of 8 Gy in 1 fraction. Three of these lesions went on to have a CR. Lesions that had a PR/NR were large (>14 cm) and involved the anterior thigh, posterior thigh, left buttock, and posterior neck. Tumor stage lesions responded equally well as plaque or patch lesions. Twelve of these lesions in three patients were those that were persistent after total skin electron therapy (TSET) to a dose of 36 Gy in 24 fractions. These lesions were in areas of skin folds and were treated 6–8 weeks after completion of TSET. CR was achieved in all these residual lesions with an additional single-fraction dose of 8 Gy. No treatment-related toxicity was observed in any of the patients.

Conclusion

Single-fraction radiation therapy is a highly effective palliative approach for treating limited extent CTCL lesions with minimal toxicity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Weinstock MA, Reynes JF (1999) The changing survival of patients with mycosis fungoides: a population-based assessment of trends in the United States. Cancer 85(1):208–212

    Article  CAS  PubMed  Google Scholar 

  2. Korgavkar K, Xiong M, Weinstock M (2013) Changing incidence trends of cutaneous T-cell lymphoma. JAMA Dermatol 149(11):1295–1299

    Article  PubMed  Google Scholar 

  3. Pimpinelli N et al (2005) Defining early mycosis fungoides. J Am Acad Dermatol 53(6):1053–1063

    Article  PubMed  Google Scholar 

  4. Olsen E et al (2007) Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 110(6):1713–1722

    Article  CAS  PubMed  Google Scholar 

  5. Kaye FJ et al (1989) A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides. N Engl J Med 321(26):1784–1790

    Article  CAS  PubMed  Google Scholar 

  6. Elsayad K et al (2015) Total skin electron beam for primary cutaneous T-cell lymphoma. Int J Radiat Oncol Biol Phys 93(5):1077–1086

    Article  PubMed  Google Scholar 

  7. Piccinno R, Caccialanza M, Percivalle S (2009) Minimal stage IA mycosis fungoides. Results of radiotherapy in 15 patients. J Dermatolog Treat 20(3):165–168

    Article  CAS  PubMed  Google Scholar 

  8. Wilson LD, Kacinski BM, Jones GW (1998) Local superficial radiotherapy in the management of minimal stage IA cutaneous T-cell lymphoma (mycosis fungoides). Int J Radiat Oncol Biol Phys 40(1):109–115

    Article  CAS  PubMed  Google Scholar 

  9. Micaily B et al (1998) Radiotherapy for unilesional mycosis fungoides. Int J Radiat Oncol Biol Phys 42(2):361–364

    Article  CAS  PubMed  Google Scholar 

  10. Thomas TO et al (2013) Outcome of patients treated with a single-fraction dose of palliative radiation for cutaneous T-cell lymphoma. Int J of Radiat Oncol* Biol* Phys 85(3):747–753

  11. Specht L et al (2015) Modern radiation therapy for primary cutaneous lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 92(1):32–39

    Article  PubMed  Google Scholar 

  12. Cotter GW et al (1983) Palliative radiation treatment of cutaneous mycosis fungoides—a dose response. Int J Radiat Oncol Biol Phys 9(10):1477–1480

    Article  CAS  PubMed  Google Scholar 

  13. Goddard AL et al (2015) Palliative therapy for recalcitrant cutaneous T-cell lymphoma of the hands and feet with low-dose, high dose-rate brachytherapy. JAMA Dermatol 151(12):1354–1357

    Article  PubMed  Google Scholar 

  14. Olsen EA et al (2011) Clinical end points and response criteria in mycosis fungoides and Sezary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States cutaneous lymphoma consortium, and the cutaneous lymphoma task force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol 29(18):2598–2607

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We would like to thank Stephanie Stebens, MLIS, and Sarah Whitehouse, MAW, for their kind review and help with preparation of this manuscript.

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI, 48202, USA

    Ankit Modh & Farzan Siddiqui

  2. Department of Dermatology, Henry Ford Hospital, Detroit, MI, USA

    Chauncey A. McHargue & Henry W. Lim

Authors
  1. Ankit Modh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chauncey A. McHargue
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Henry W. Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Farzan Siddiqui
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Farzan Siddiqui.

Ethics declarations

Funding

No funding was received for this study.

Conflicts of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

For this type of study, formal consent is not required.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Modh, A., McHargue, C.A., Lim, H.W. et al. Single-fraction radiation therapy provides highly effective palliation for cutaneous T cell lymphoma. J Radiat Oncol 6, 301–305 (2017). https://doi.org/10.1007/s13566-017-0308-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13566-017-0308-5

Keywords

Search

Navigation